Published in Cancer Weekly, February 28th, 2006
"The transcription factor C/EBP alpha controls differentiation and proliferation in normal granulopoiesis in a stage-specific manner. Loss of C/EBPa function in myeloid cells in vitro and in vivo leads to a block to myeloid differentiation similar to that which is observed in malignant cells from patients with acute myeloid leukemia.
"The finding of C/EBPa alterations in subgroups of acute myeloid leukemia patients suggests a direct link between critically decreased C/EBP alpha function and the development of the disorder," scientists in Switzerland...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.